Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis.

Gu, Ruicai; Kim, Tae-Dong; Jiang, Hanlin; Shin, Sook; Oh, Sangphil; Janknecht, Ralf

Gu, Ruicai; Kim, Tae-Dong; Jiang, Hanlin; Shin, Sook; Oh, Sangphil; Janknecht, Ralf.

Afiliação

Gu R; Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Kim TD; Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Jiang H; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Shin S; Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Oh S; Stephenson Cancer Center, Oklahoma City, OK, United States.
Janknecht R; Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.

Front Oncol ; 13: 1295613, 2023.

Article em En | MEDLINE | ID: mdl-38045004

Palavras-chave

CBLC; KDM4D; PLAGL1; gene expression; histone demethylase; posttranslational modification; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google